Co-expression of GRK2 reveals a novel conformational state of the μ-opioid receptor

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Nickolls, Sarah A ^a   Humphreys, Sian ^a   Clark, Mellissa ^a   McMurray, Gordon ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ARRESTIN; ENDOMORPHIN 1; ENDOMORPHIN 2; G PROTEIN COUPLED RECEPTOR KINASE 2; MORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; NALOXONE; OXYCODONE; PERTUSSIS TOXIN; ADRBK1 PROTEIN, HUMAN; RETINA S ANTIGEN;

ARTICLE; BINDING AFFINITY; BINDING ASSAY; CONTROLLED STUDY; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; LIGAND BINDING; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; AGONISTS; CELL LINE; CHEMISTRY; GENE EXPRESSION; GENETICS; METABOLISM; PROTEIN CONFORMATION;

ARRESTINS; CELL LINE; G-PROTEIN-COUPLED RECEPTOR KINASE 2; GENE EXPRESSION; HUMANS; PROTEIN CONFORMATION; RECEPTORS, OPIOID, MU;

EID: 84893394832     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083691     Document Type: Article

References (37)

1. Berg KA, Maayani S, Goldfarb J, Scaramellini C, Leff P, et al. (1998) Effector pathway dependent relative efficacy at serotonin type 2A and 2C receptors: Evidence for agonist directed trafficking of receptor stimulus. Mol Pharmacol 36: 601-607.
2. Wenzel-Seifert K, Seifert R (2000) Molecular analysis of β2 adrenoceptor coupling to Gs, Gi and Gq proteins. Mol Pharmacol 58: 954-966.
3. Nickolls SA, Strange PG (2004) The influence of G protein subtype on agonist action at D2 dopamine receptors. Neuropharmocology 47: 860-72. (Pubitemid 39440980)
4. Lohse MJ, Andexinger S, Pitcher J, Trukawinski S, Codina J, et al. (1992) Receptor-specific desensitization with purified proteins. Kinase dependence and receptor specificity of beta-arrestin and arrestin in the beta 2-adrenergic receptor and rhodopsin systems. J Biol Chem 267:8558-8564.
5. Perry SJ, Lefkowitz RJ (2002) Arresting developments in heptahelical receptor signalling and regulation. Trends Cell Biol 12: 130-138. (Pubitemid 34164652)
6. Azzi M, Charest PG, Angers S, Rousseau G, Kohout T, et al. (2003) β-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors. Proc Nat Acad Sci 100: 11406-11411.
7. Wei H, Ahn S, Shenoy SK, Karnik SS, Hunyady L, et al. (2003) Independent β-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2. Proc Nat Acad Sci 100: 10782-10787. (Pubitemid 37140105)
8. Kenakin T, Miller LJ (2011) Seven Transmembrane Receptors as Shapeshifting Proteins: The Impact of Allosteric Modulation and Functional Selectivity on New Drug Discovery. Pharmacol Rev 62: 265-304.
9. Evron T, Daigle TL, Caron MG (2012) GRK2: multiple roles beyond G protein-coupled receptor desensitization. Trends Pharmacol Sci 33: 154-164.
10. Doll C, Poll F, Peuker K, Loktev A, Gluck L, et al. (2012) Deciphering μ-opioid receptor phosphorylation and dephosphorylation in HEK293 cells. Br J Pharmacol 167: 1259-1270.
11. Chen YJ, Oldfield S, Butcher AJ, Tobin AB, Saxena K, et al. (2013) Identification of phosphorylation sites in the COOH-terminal tail of the μ-opioid receptor. J Neurochem 124: 189-199.
12. Arden JR, Segredo V, Wang Z, Lameh J, Sadée W (1995) Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged mu-opioid receptor expressed in HEK 293 cells. J Neurochem 65: 1636-45.
13. Burford NT, Tolbert LM, Sadée W (1998) Specific G protein activation and mu-opioid receptor internalization caused by morphine, DAMGO and endomorphin 1. Eur J Pharmacol 342: 123-126. (Pubitemid 28131354)
14. Whistler JL, von Zastrow M (1998) Morphine-activated opioid receptors elude desensitization by β-arrestin. Proc Natl Acad Sci USA 95: 9914-9919. (Pubitemid 28415269)
15. Zhang J, Ferguson SS, Barak LS, Bodduluri SR, Laporte SA, et al. (1998) Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness. Proc Natl Acad Sci USA 95: 7157-7162. (Pubitemid 28278123)
16. Haberstock-Debic H, Kim KA, Yu YJ, von Zastrow M (2005) Morphine promotes rapid, arrestin-dependent endocytosis of mu-opioid receptors in striatal neurons. J Neurosci 25: 7847-7857. (Pubitemid 41208657)
17. Bohn LM, Lefkowitz RJ, Gainetdinov RR, Peppel K, et al. (1999) Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science 286: 2495-2498.
18. Raehal KM, Walker JK, Bohn LM (2005) Morphine side effects in β-arrestin 2 knockout mice. J Pharmacol Exp Ther 314: 1195-1201. (Pubitemid 41205984)
19. DeWire SM, Yamashita DS, Rominger DH, Liu GL, Cowan CL, et al. (2013) A G protein biased ligand at the m-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared to morphine. J Pharm Exp Ther 344: 708-717.
20. Cheng Y, Prusoff WH (1973) Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (IC50) of an emzymic reaction. Biochem Pharmacol 55: 3099-3108.
21. Jacobson AR, Gintzler AR, Sayre LM (1989) Minimum-structure enkephalin analogs incorporating L-tyrosine, D (or L)-phenylalanine and a diamine spacer. J Med Chem 32: 1708-1717. (Pubitemid 19204349)
22. Black JW, Leff P (1983) Operational models of pharmacological agonism. Proc Royal Soc Lon 220: 141-162. (Pubitemid 14217337)
23. Nickolls SA, Waterfield A, Williams RE, Kinloch R (2011) Understanding the effect of different assay formats on agonist parameters: a study using the μ-opioid receptor. J Biomol Screen 16: 706-716.
24. Chen C, Yin J, de Riel K, DesJarlais RL, Raveglia LF, et al. (1996) Determination of the amino acid involved in [3H]β-funaltrexamine covalent binding in the cloned rat μ opioid receptor. J Biol Chem 271: 21422-21429.
25. Kenakin T, Christopoulos C (2013) Signalling bias in new drug discovery: detection, quantification and therapeutic effect. Nat Rev Drug Disc 12: 205-216.
26. Mary S, Damian M, Louet M, Floquet N, Fehrentz J, et al. (2012) Ligands and signaling proteins govern the conformational landscape explored by a G protein coupled receptor. Proc Natl Acad Sci 109: 8304-8309.
27. Krasel C, Bunemann M, Lorenz K, Lohse MJ (2005) β-arrestin binding to the β2-adrenergic receptor requires both receptor phosphorylation and receptor activation. J Biol Chem 280: 9528-9535.
28. Yan F, Mosier PD, Westkaemper RB, Roth BL (2008) Gα-subunits differentially alter the conformation and agonist affinity of κ-opioid receptors. Biochemistry 47: 1567-1578. (Pubitemid 351231207)
29. Magnan R, Escrieut C, Gigoux V, Kavita DE, Clerc P, et al. (2013) Distinct CCK-2 receptor conformations associated with β-arrestin-2 recruitment or phospholipase-C activation revealed by a biased antagonist. J Am Chem Soc 135: 2560-2673.
30. Pitcher JA, Inglese J, Higgins JB, Arriza JL, Casey PJ, et al. (1992) Role of beta gamma subunits of G proteins in targeting the beta-adrenergic receptor kinase to membrane-bound receptors, Science 257: 1264-1267.
31. Li J, Xiang B, Su W, Zhang X, Huang Y, et al. (2003) Agonist-induced formation of opioid receptor-G protein-coupled receptor kinase (GRK)-G beta gamma complex on membrane is required for GRK2 function in vivo. J Biol Chem 278: 30219-30226. (Pubitemid 36962416)
32. Rivero G, Llorente J, McPherson J, Cooke A, Mundell SJ, et al. (2012) Endomorphin-2: A biased agonist at the μ-opioid receptor. Mol Pharm 82: 178-188.
33. Jorgensen R, Norklit Roed S, Heding A, Elling CE (2011) Beta-arrestin2 as a competitor for GRK2 interaction with the GLP-1 receptor upon receptor upon receptor activation. Pharmacology 88: 174-181.
34. Liu JC, Prather PL (2001) Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment. Mol Pharmacol 60: 53-62.
35. Wang D, Raehal KM, Lin ET, Lowery JJ, Kieffer BL, et al (2004) Basal signalling activity of mu opioid receptor in mouse brain:role in narcotic dependence. J Pharmacol Exp Ther 308: 512-520. (Pubitemid 38134212)
36. Birdsong WT, Arttamangkul S, Clark MJ, Cheng K, Rice KC, et al (2013) Increased agonist affinity at the μ-opioid receptor induced by prolonged agonist exposure. J Neurosci 33:4118-4127.
37. Nobles KN, Xiao K, Ahn S, Shukla AK, Lam CM, et al (2012) Distinct phosphorylation sites on the β2-adrenergic establish a barcode that encodes differential functions of β-arrestin. Science Signaling 4: 1-10.